glp 1 mechanism of action diabetes Glucagon-like peptide receptor agonists: cardiovascular benefits and mechanisms GLP-1RAs Reduce External Eating Behavior

Description

Factors associated with weight loss response to GLP-1 analogues for obesity treatment: a retrospective cohort analysis

These fates of fatty acids that enter the brain have been worked out with the use of a selective carnitine palmitoyltransferase 1 (CPT-1) inhibitor

Type 1 vs Type 2 Diabetes: A Fundamental Difference Type 2 Diabetes Insulin is still produced (at least initially) There is insulin resistance GLP-1 agonists stimulate insulin secretion (in a glucose-dependent way) Type 1 Diabetes The pancreas produces little to no insulin Insulin must be given externally There is no reserve safety net In Type 1 diabetes, insulin is not just for glucose control it is a critical anti-ketogenic hormone

Those taking tirzepatide, managed an additional 5.5% WL from randomisation, compared to those taking placebo who experienced mean weight regain of 14% from randomisation [49]